🔗 Share this article

This year's Nobel Prize in Physiology or Medicine was awarded for revolutionary discoveries that illuminate how the immune system attacks harmful pathogens while protecting the healthy tissues.

A trio of esteemed researchers—from Japan Prof. Sakaguchi and American scientists Mary Brunkow and Dr. Ramsdell—received this accolade.

Their work identified unique "sentinels" within the immune system that eliminate malfunctioning defense cells that could harming the body.

These findings are now enabling new therapies for immune disorders and cancer.

These winners will divide a monetary award worth 11m SEK.

Crucial Findings

"The research has been decisive for understanding how the immune system functions and the reason we do not all suffer from severe self-attack conditions," stated the chair of the award panel.

This team's studies address a core mystery: In what way does the defense system defend us from numerous infections while leaving our own tissues unharmed?

Our body's protection system uses white blood cells that scan for indicators of disease, including pathogens and germs it has never encountered.

These cells utilize sensors—called receptors—that are generated randomly in a vast number of variations.

This gives the defense network the capacity to combat a wide array of threats, but the unpredictability of the process inevitably produces immune cells that may attack the host.

Security Guards of the Immune System

Scientists previously understood that some of these harmful white blood cells were destroyed in the immune organ—where white blood cells develop.

The latest Nobel Prize recognizes the discovery of regulatory T-cells—known as the immune system's "security guards"—which patrol the body to neutralize other defenders that assault the body's own tissues.

It is known that this process malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

The prize committee stated, "These discoveries have established a novel area of research and accelerated the creation of innovative therapies, for instance for tumors and immune disorders."

Regarding cancer, T-regs block the system from attacking the growth, so studies are aimed at lowering their numbers.

In autoimmune diseases, trials are testing increasing regulatory T-cells so the body is not being harmed. A similar method could also be effective in minimizing the chances of transplanted organ failure.

Innovative Studies

Prof Shimon Sakaguchi, of a Japanese institution, conducted experiments on rodents that had their thymus removed, leading to self-attack conditions.

The researcher demonstrated that introducing defense cells from healthy animals could stop the disease—suggesting there was a system for blocking defenders from harming the body.

Mary Brunkow, from the Institute for Systems Biology in Seattle, and Dr. Ramsdell, currently at a biotech firm in a California city, were studying an genetic autoimmune disease in rodents and people that led to the identification of a gene critical for how regulatory T-cells function.

"The pioneering work has revealed how the body's defenses is controlled by T-reg cells, stopping it from mistakenly attacking the body's own tissues," commented a leading biological science expert.

"The research is a striking example of how fundamental physiological research can have far-reaching implications for public health."